Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 294
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00106860 | A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder | ||
| NCT04421456 | Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment | ||
| NCT01241344 | Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease | ||
| NCT01681121 | A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy | ||
| NCT02851407 | Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-Occlusive Disease in Adult and Pediatric Patients | ||
| NCT03406702 | CX-8998 for Absence Seizures | ||
| NCT02419469 | Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | ||
| NCT01812603 | A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma | ||
| NCT07278505 | Study of Cannabidiol and Neuroimaging on Stress | ||
| NCT06695845 | A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors | ||
| NCT00590915 | Erwinase Master Treatment Protocol | ||
| NCT03954106 | A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity | ||
| NCT03878199 | Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms | ||
| NCT02038699 | A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer | ||
| NCT03533114 | A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension | ||
| NCT06261450 | Effect of CBD on the Brain | ||
| NCT02348606 | "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" | ||
| NCT01361607 | Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer | ||
| NCT00713817 | A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain | ||
| NCT01643408 | A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy | ||
| NCT07153055 | Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer | ||
| NCT04530604 | Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) | ||
| NCT04075747 | A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia | ||
| NCT00003966 | Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation | ||
| NCT00713323 | A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain. | ||
| NCT07282587 | Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma | ||
| NCT01322139 | Sativex Thorough QT/QTc Study | ||
| NCT01769170 | A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients | ||
| NCT04894591 | To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC) | ||
| NCT04617002 | Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas | ||
| NCT01426295 | Pharmaco-economic Study of a New Medical Device Performed From the Perspective of the Hospital | ||
| NCT01323465 | Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex | ||
| NCT05260528 | CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics | ||
| NCT04899947 | Child and Adolescent Registry for Participants With Narcolepsy | ||
| NCT02533115 | EAP of CPX-351 (VYXEOS) for Patients 60-75 Years of Age With Secondary AML | ||
| NCT02806908 | Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy | ||
| NCT05055271 | Delphi Consensus Excessive Daytime Sleepiness in OSA | ||
| NCT05044819 | Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution | ||
| NCT02369471 | A Study of GWP42006 in People With Focal Seizures - Part A | ||
| NCT02544763 | A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6) | ||
| NCT04133480 | Investigation of Cognitive Outcomes With Cannabidiol Oral Solution | ||
| NCT03339297 | An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD) | ||
| NCT02224703 | GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome | ||
| NCT04732065 | ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors | ||
| NCT05772429 | Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting | ||
| NCT06261502 | Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome | ||
| NCT01606176 | A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin | ||
| NCT03032016 | European VOD Registry | ||
| NCT03904251 | CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia | ||
| NCT05091567 | A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer |
